Cancer Letters: Volume 580 to Volume 588

Journal Overview: Cancer Letters

Cancer Letters is an esteemed international journal dedicated to advancing knowledge in the field of oncology, particularly focusing on basic and translational research. The journal provides a platform for the publication of full-length articles and Mini Reviews that cover a wide spectrum of topics in cancer research. It also features Special Issues that spotlight timely and relevant areas within the field.

Key areas of interest and research topics covered in Cancer Letters include:

1. Molecular Genetics and Cell Biology of Cancer: Studies investigating the genetic and cellular mechanisms underlying cancer development and progression.
2. Radiation Biology: Research exploring the effects of radiation on cancer cells and tissues, with a focus on therapeutic applications.
3. Molecular Pathology: Investigations into the molecular and genetic alterations associated with cancer, aiding in the diagnosis and understanding of the disease.
4. Hormones and Cancer: Studies examining the role of hormones and hormonal imbalances in cancer development.
5. Viral Oncology: Research on the oncogenic potential of viruses and their contributions to cancer formation.
6. Metastasis: Investigations into the processes and factors involved in cancer metastasis, a key determinant of cancer progression.
7. Chemoprevention: Research on strategies and agents for preventing cancer development, including the use of metronomic chemotherapy.

The journal places a particular emphasis on experimental therapeutics, with a focus on targeted therapies that hold promise for personalized cancer medicine. This includes research on the development and application of targeted treatments tailored to individual patients.

Cancer Letters serves as a valuable resource for researchers, scientists, clinicians, and professionals in the field of oncology. By publishing research articles and Mini Reviews, it contributes to the dissemination of critical findings and advancements that impact our understanding of cancer and the development of novel therapeutic approaches.

All content published in Cancer Letters is presented in the English language, ensuring that research findings are accessible to a global audience of scientists and healthcare practitioners.